Lexicon Pharmaceuticals Inc
NASDAQ:LXRX

Watchlist Manager
Lexicon Pharmaceuticals Inc Logo
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
Watchlist
Price: 0.7734 USD -1.45% Market Closed
Market Cap: 279.6m USD
Have any thoughts about
Lexicon Pharmaceuticals Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-0.6
Current
-2.9
Median
6.2
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-0.6
=
Enterprise Value
121.1m USD
/
Operating Cash Flow
-207.9m USD
All Countries
Close
 
US
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
Average EV/OCF: 22.1
Negative Multiple: -0.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 143.2
US
Abbvie Inc
NYSE:ABBV
22.2
US
Amgen Inc
NASDAQ:AMGN
26
US
Gilead Sciences Inc
NASDAQ:GILD
11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -470.8
AU
CSL Ltd
ASX:CSL
34.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -133.5

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More